Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACT-T1D: Autologous FMT for Type 1 Diabetes
NCT07083882Phase 2Recruiting
- Sponsor
- University of Amsterdam
- Start
- Sep 2025
- Primary completion
- Sep 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in type 1 diabetes mellitus (T1D), sponsored by University of Amsterdam. Started Sep 2025; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07083882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07083882.